
Personalis PSNL
€ 6.77
-0.13%
Quartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Land |
|
IPO-Jahr |
2019 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
59.3 M |
Marktkapitalisierung |
$ 471 M |
EBITDA (LTM) |
$ -66.9 M |
P/E (LTM) |
-6.17 |
P/S (LTM) |
6.05 |
EPS (LTM) |
-1.29 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Brainsway Ltd.
BWAY
|
$ 19.04 | 0.11 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 20.25 | -3.5 % | $ 217 M | Nasdaq Global Market | ||
|
Co-Diagnostics
CODX
|
$ 5.35 | 5.87 % | $ 157 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 38.31 | -1.52 % | $ 1.06 B | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Danaher Corporation
DHR
|
$ 230.53 | 0.7 % | $ 169 B | NYSE,SPB | ||
|
DexCom
DXCM
|
$ 66.36 | -0.02 % | $ 25.6 B | Nasdaq Global Select Market,SPB | ||
|
BioNano Genomics
BNGO
|
$ 1.56 | 1.96 % | $ 1.98 M | Nasdaq Capital Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 11.2 | -1.58 % | $ 318 M | Nasdaq Capital Market | ||
|
Exact Sciences Corporation
EXAS
|
$ 101.8 | 0.24 % | $ 18.9 B | Nasdaq Capital Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 225.76 | 0.16 % | $ 40.9 B | NYSE,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 25.77 | -1.9 % | $ 779 M | Nasdaq Global Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
CareDx, Inc
CDNA
|
$ 19.08 | 1.27 % | $ 1.03 B | Nasdaq Global Market,SPB | ||
|
Celcuity
CELC
|
$ 99.7 | -0.05 % | $ 3.93 B | Nasdaq Global Select Market | ||
|
Anixa Biosciences
ANIX
|
$ 3.11 | -0.32 % | $ 99.2 K | Nasdaq Capital Market | ||
|
Myriad Genetics
MYGN
|
$ 6.23 | 1.22 % | $ 564 M | Nasdaq Global Select Market,SPB | ||
|
Guardant Health
GH
|
$ 101.54 | -0.59 % | $ 12.5 B | Nasdaq Global Select Market,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 4.21 | -7.06 % | $ 2.26 M | Nasdaq Global Select Market | ||
|
NeoGenomics
NEO
|
$ 11.7 | -0.51 % | $ 1.48 B | Nasdaq Global Select Market,SPB | ||
|
National Research Corporation
NRC
|
$ 18.42 | -1.86 % | $ 452 M | Nasdaq Global Select Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
OPKO Health
OPK
|
$ 1.32 | 4.37 % | $ 916 M | Nasdaq Global Select Market | ||
|
Koninklijke Philips N.V.
PHG
|
$ 27.16 | 0.3 % | $ 20 B | NYSE | ||
|
Precipio
PRPO
|
$ 23.35 | 1.61 % | $ 30.3 M | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Illumina
ILMN
|
$ 132.66 | 1.14 % | $ 21.1 B | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 200.04 | 0.28 % | $ 10.3 B | NYSE,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 172.92 | -0.35 % | $ 19.2 B | NYSE,SPB | ||
|
Biodesix
BDSX
|
$ 6.72 | -1.25 % | $ 871 M | Nasdaq Global Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 251.95 | 0.43 % | $ 21.1 B | NYSE,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 188.4 | 3.39 % | $ 15.5 B | Nasdaq Global Select Market,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 664.7 | -1.75 % | $ 54.8 B | Nasdaq Global Select Market,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 67.47 | 1.38 % | $ 4.67 B | Nasdaq Global Select Market,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 406.1 | 0.85 % | $ 29.8 B | NYSE,SPB | ||
|
Agilent Technologies
A
|
$ 137.01 | 0.69 % | $ 41.7 B | NYSE,SPB |